A Case of Multiple System Atrophy-Parkinsonism Type (MSA-P) with Gait Disturbance and Posture Instability Treated with Korean Medicine
![]() |
Lee, Sang-hwa
(Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong)
Shin, Hee-yeon (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Jeong, Hye-seon (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Kim, Seo-young (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Yang, Seung-bo (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Cho, Seung-yeon (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Park, Jung-mi (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Ko, Chang-nam (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) Park, Seong-uk (Stroke and Neurological Disorders Center, Kyung Hee University Korean Medicine Hospital at Gangdong) |
1 | Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363(9423):1183-93. |
2 | Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med 2015;372(3):249-63. DOI |
3 | Yang SB, Kim YJ, Lee HM, Lee HJ, Cho SY, Park JM, et al. Effects of Korean Medicine on Patients with Idiopathic Parkinson's Disease: A Retrospective Study. J Int Korean Med 2016;37(4):653-60. DOI |
4 | Yang SB, Kim YJ, Lee HM, Lee SH, Cho SY, Park JM, et al. Effects of Korean Medicine on Postural Instability and Gait Difficulty in Patient with Parkinsonism: Retrospective Study. J Korean Med 2017;38(3):96-102. DOI |
5 | Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, et al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 2015;85(5):404-12. DOI |
6 | Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125(Pt 5):1070-83. DOI |
7 | Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004 Dec;19(12):1391-402. DOI |
8 | Quinn N. A short clinical history of multiple system atrophy. Clin auton res 2015;25(1):3-7. DOI |
9 | Roncevic D, Palma JA, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. J Neural Transm 2014;121(5):507-12. DOI |
10 | Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49(5):1284-8. DOI |
11 | Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11(4):361-8. DOI |
12 | Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, et al. Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? J Neurol 2002;249(7):847-54. DOI |
13 | Brooks DJ, Seppi K. Neuroimaging Working Group on, M.S.A. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009;24(7):949-64. DOI |
14 | Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12(2):133-47. DOI |
15 |
Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, et al. Cellular milieu imparts distinct pathological |
16 | Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, Rascol O. A cross-sectional study on drug use in multiple system atrophy. CNS Drugs 2014;28(5):483-90. DOI |
17 | Lee SH, Jeong JY, Cho MR. A Clinical Case Report on The Improvement of Respiratory Function of A Fascioscapulohumeral Muscular Dystrophy Patient After Korean Medical Treatment. J Acupunct Res 2015;32(4):195-201. DOI |
18 | Korean Pharmacopuncture Institute. Pharmacopuncture treatment guidelines. Seoul: Korean Pharmacopuncture Seoul Institute; 2000, p. 161-2, 284, 313. |
19 | Kim HR, Jeong HS, Shin HY, Choi JW, Yang SB, Cho SY, et al. A Case of Korean Medical Treatment on Parkinson's Disease Patient with Postural Instability, Presenting as Camptocormia. J Int Korean Med 2019;40(2):220-7. DOI |
20 | Kim JH, Lee HM, Kim YJ, Lee BY, Cho SY, Park JM, et al. A Case of Torticollis with Korean Medicine. Journal of the society of Stroke on Korean Med2016;17(1):15-22. |
21 | Kim MK, Lu HY, Cho SY, Jung WS, Moon SK, Park JM, et al. Efficacy of Electroacupuncture with Dysphagia Caused by Stroke - Double-blind, Randomized Controlled Trial -. J Korean Med 2014;35(1):26-40. DOI |
22 | Doo KH, Lee JH, Cho SY, Jung WS, Moon SK, Park JM, et al. A Prospective Open-Label Study of Combined Treatment for Idiopathic Parkinson's Disease Using Acupuncture and Bee Venom Acupuncture as an Adjunctive Treatment. J Altern Complement Med 2015;21(10):598-603. DOI |
23 | Hwang MW. Lecture on Sasang Constitutional Medicine. Seoul: Koonja; 2012, p. 261, 264, 272. |
24 | Jeong SS, An TH, Park SI, Kim JH, Seo HS, Ryu CG, et al. A Case Report of the Patient with Multiple System Atrophy Evaluated by Unified Multiple System Atrophy Rating Scale (UMSARS). J Int Korean Med 2012;33(1):102-10. |
25 | Lee JE, Lim JW, Yei YC, Kim YS, Cho KH, Moon SK, et al. A case study of a MSA-P patients with Gait Disturbance treated by Korean Medical Treatment. J Int Korean Med 2013;spr:201-5. |
![]() |